Diag Capital Management as of Dec. 31, 2018
Portfolio Holdings for Diag Capital Management
Diag Capital Management holds 40 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Baxter International (BAX) | 6.3 | $5.7M | 86k | 65.82 | |
| Athenex | 6.1 | $5.4M | 429k | 12.69 | |
| Zimmer Holdings (ZBH) | 5.5 | $4.9M | 48k | 103.72 | |
| Abbvie (ABBV) | 5.2 | $4.6M | 50k | 92.19 | |
| Incyte Corporation (INCY) | 5.1 | $4.6M | 72k | 63.59 | |
| Quanterix Ord (QTRX) | 4.6 | $4.1M | 224k | 18.31 | |
| Celgene Corporation | 4.5 | $4.0M | 63k | 64.09 | |
| Amgen (AMGN) | 4.4 | $3.9M | 20k | 194.68 | |
| Foamix Pharmaceuticals | 3.7 | $3.3M | 146k | 22.60 | |
| Medtronic (MDT) | 3.7 | $3.3M | 36k | 90.96 | |
| Quotient | 3.6 | $3.2M | 527k | 6.12 | |
| Pacira Pharmaceuticals conv | 3.6 | $3.2M | 75k | 43.02 | |
| Takeda Pharmaceutical (TAK) | 3.3 | $3.0M | 177k | 16.82 | |
| Abbott Laboratories (ABT) | 3.1 | $2.8M | 39k | 72.33 | |
| Zai Lab (ZLAB) | 3.1 | $2.8M | 120k | 23.22 | |
| Mylan Nv | 3.0 | $2.7M | 99k | 27.40 | |
| Polarityte | 2.8 | $2.5M | 183k | 13.49 | |
| Viewray (VRAYQ) | 2.7 | $2.4M | 397k | 6.07 | |
| Regeneron Pharmaceuticals (REGN) | 2.4 | $2.2M | 5.8k | 373.45 | |
| Teva Pharmaceutical Industries (TEVA) | 2.4 | $2.2M | 140k | 15.42 | |
| Akorn | 2.4 | $2.1M | 634k | 3.39 | |
| Haemonetics Corporation (HAE) | 2.4 | $2.1M | 21k | 100.05 | |
| Argenx Se (ARGX) | 1.8 | $1.6M | 17k | 96.10 | |
| Biohaven Pharmaceutical Holding | 1.6 | $1.4M | 38k | 36.98 | |
| Merit Medical Systems (MMSI) | 1.6 | $1.4M | 25k | 55.79 | |
| Sanofi-Aventis SA (SNY) | 1.5 | $1.3M | 30k | 43.42 | |
| Gw Pharmaceuticals Plc ads | 1.5 | $1.3M | 14k | 97.40 | |
| Livanova Plc Ord (LIVN) | 1.2 | $1.1M | 12k | 91.45 | |
| Molecular Templates | 1.1 | $985k | 244k | 4.04 | |
| Verrica Pharmaceuticals (VRCA) | 1.0 | $937k | 115k | 8.15 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $876k | 12k | 71.42 | |
| Dentsply Sirona (XRAY) | 0.8 | $757k | 20k | 37.20 | |
| Axonics Modulation Technolog (AXNX) | 0.8 | $702k | 47k | 15.10 | |
| Arya Sciences Acquisition Co unit 10/04/2023 | 0.6 | $522k | 51k | 10.34 | |
| Adma Biologics (ADMA) | 0.5 | $435k | 182k | 2.39 | |
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $326k | 2.9k | 112.80 | |
| Arvinas Ord (ARVN) | 0.3 | $311k | 24k | 12.85 | |
| Novavax Inc note 3.750% 2/0 | 0.3 | $286k | 155k | 1.84 | |
| Neos Therapeutics | 0.3 | $278k | 169k | 1.65 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $95k | 1.5k | 63.63 |
